HUMAN .BETA.-AMYLOID PEPTIDE (1-42)

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Mon Mar 31 22:55:20 GMT 2025` Edited by `admin` on `Mon Mar 31 22:55:20 GMT 2025`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	042A8N37WH
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

HUMAN .BETA.-AMYLOID PEPTIDE (1-42)

Common Name

English

A.BETA.42

Preferred Name

English

ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA

Common Name

English

ABETA 1-42

Common Name

English

A.BETA.1-42

Common Name

English

AMYLOID .BETA. 1-42

Common Name

English

GLYCOPROTEIN, AMYLOID A4 (HUMAN CLONE .LAMBDA.APCP168I4 N-TERMINAL 42-AMINO-ACID FRAGMENT)

Common Name

English

PEPTIDE .BETA. (HUMAN AMYLOID)

Common Name

English

BETA AMYLOID PEPTIDE (1-42)

Common Name

English

A.BETA.42 [MI]

Common Name

English

Code System Code Type Description

CHEBI

64647

Created by admin on Mon Mar 31 22:55:20 GMT 2025 , Edited by admin on Mon Mar 31 22:55:20 GMT 2025

PRIMARY

FDA UNII

042A8N37WH

Created by admin on Mon Mar 31 22:55:20 GMT 2025 , Edited by admin on Mon Mar 31 22:55:20 GMT 2025

PRIMARY

PUBCHEM

57339251

Created by admin on Mon Mar 31 22:55:20 GMT 2025 , Edited by admin on Mon Mar 31 22:55:20 GMT 2025

PRIMARY

MERCK INDEX

m1878

Created by admin on Mon Mar 31 22:55:20 GMT 2025 , Edited by admin on Mon Mar 31 22:55:20 GMT 2025

PRIMARY

Merck Index

EPA CompTox

DTXSID70856172

Created by admin on Mon Mar 31 22:55:20 GMT 2025 , Edited by admin on Mon Mar 31 22:55:20 GMT 2025

PRIMARY

CAS

107761-42-2

Created by admin on Mon Mar 31 22:55:20 GMT 2025 , Edited by admin on Mon Mar 31 22:55:20 GMT 2025

PRIMARY

Related Record Type Details


					5K8EAX0G53

INHIBITOR OF AGGREGATION->TARGET

Comments:

A? was maintained in a random-coil/?-helical rich conformation in the presence of Tramiprosate at a 20:1 ratio of Tramiprosate:A?. Binds and shows anti-fibrillogenic activity.

Amount:


					GUU94434KC

PAL 1-15

VACCINE ANTIGEN->TARGET

Amount:


					UH32L7RML6

LIGAND->TARGET

Comments:

Targets soluble A? monomer to shift oligomer equilibrium and prevent direct neurotoxicity from soluble forms.

Amount:


					C35RF1MWQZ

INHIBITOR OF RELEASE->TARGET

Amount:


					6W15Z5R0RU

FLORBETAPIR F-18

RADIOLIGAND->TARGET

Amount:


					5D6PWO0333

LIGAND->TARGET

Comments:

Designed to increase the clearance from the brain of soluble A?, peptides that may lead to toxic effects in the synapses and precede the deposition of fibrillary amyloid.

Amount:


					F7MN148019

RN-6G

INHIBITOR -> TARGET


					BEX3397O3Z

D3-FLORBETAPIR F-18

RADIOLIGAND->TARGET

Amount:


					1051LN7FLM

SEN-1176

INHIBITOR OF AGGREGATION->TARGET

Comments:

Inhibitor of neuroinflammation caused by A?1–42-induced macrophage production of nitric oxide, TNF-alpha, IL-1beta, and IL-6.

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:SEQUENCE(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL